Last reviewed · How we verify
Extension Study, An Open-labelled, Multi Center, Comparative Phase I/IIa Clinical Trials to Evaluate the Efficacy and Safety of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease
The purpose of this clinical trial is to evaluate long-term safety and efficacy in patients who has history of FURESTEM-CD injection at least once.
Details
| Lead sponsor | Kang Stem Biotech Co., Ltd. |
|---|---|
| Status | UNKNOWN |
| Enrolment | 24 |
| Start date | 2015-11 |
| Completion | 2021-11 |
Conditions
- Crohn's Disease
Interventions
- stem cells
Primary outcomes
- all kinds of adverse events which occur during the clinical sutdy — 114 weeks
Safety outcome
Countries
South Korea